|
|
Volumn 16, Issue 5, 2015, Pages 259-
|
|
Clinical genetics: Sequencing for tailored melanoma immunotherapy
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
HLA ANTIGEN;
MELANOCYTE PROTEIN PMEL 17;
HLA A2 ANTIGEN;
TUMOR ANTIGEN;
BINDING AFFINITY;
CANCER IMMUNOTHERAPY;
CELLULAR IMMUNITY;
CUTANEOUS MELANOMA;
DENDRITIC CELL;
GENE MUTATION;
GENE SEQUENCE;
GENOME;
HLA SYSTEM;
HUMAN;
IMMUNE RESPONSE;
MELANOMA;
NEXT GENERATION SEQUENCING;
NOTE;
PERIPHERAL BLOOD MONONUCLEAR CELL;
PHASE 1 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
ACTIVE IMMUNIZATION;
IMMUNOLOGY;
PROCEDURES;
SKIN NEOPLASMS;
T LYMPHOCYTE;
TRANSPLANTATION;
ANTIGENS, NEOPLASM;
CANCER VACCINES;
DENDRITIC CELLS;
HLA-A2 ANTIGEN;
HUMANS;
IMMUNOTHERAPY, ACTIVE;
MELANOMA;
SKIN NEOPLASMS;
T-LYMPHOCYTES;
|
|
EID: 84928181183
PISSN: 14710056
EISSN: 14710064
Source Type: Journal
DOI: 10.1038/nrg3945 Document Type: Note |
|
Times cited : (4)
|
|
References (1)
|
